The National Science Foundation has announced the establishment of 11 new NSF National Artificial Intelligence Research Institutes, reaching a combined investment of $220 million and including a total of 40 states when adding the original seven institutes announced last year. The institutes are expected to act as connections in a broader nationwide network and will be led by NSF in partnership with the U.S.

The NIH’s High-Risk, High-Reward Research program (HRHR) has the potential to overturn fundamental paradigms, but historically the applicant and awardee pools have not fully represented the demographic and geographic diversity across the U.S. biomedical workforce, says the NIH’s deputy director for extramural research.

Contradictory to the prevailing theory that fintech companies — utilizing cutting-edge algorithms and incorporating data beyond the standard credit reports — have better insights into borrower risk profiles than traditional lenders, new research indicates that fintech borrowers are more likely to default on their loans than their counterparts who utilize traditional banks.

The Georgia Research Alliance has announced a new five-year initiative to fight sickle cell disease that will include creation of a GRA Eminent Scholar chair at the Morehouse School of Medicine (MSM), Emory University and Children’s Healthcare of Atlanta (CHOA). The Calvin Smyre GRA Eminent Scholar Chair, named for Rep.

High-risk/high-reward research can yield breakthroughs, produce new technologies, and allow the surrounding region to remain economically relevant. However, the scientific community remains concerned that research and development-focused policies, both in the U.S. and elsewhere, continue to be conservative with their goals by only encouraging incremental growth that can yield tangible results in shorter amounts of time. These concerns, and potential policy solutions, are explored in a recently published research paper by the Organization for Economic Cooperation and Development (OECD).

Helping to meet the challenge of fighting a global pandemic while growing high-quality jobs during an economic downturn, the life sciences industry showed its strength over the course of the past year. An update to the biennial Life Science Workforce Trends report from the Coalition of State Bioscience Institutes (CSBI) asserts that it is because of the industry’s skilled-talent base and sets out to assess the industry’s position and priorities in 2021, focusing on its demands for workforce and talent.

NIH just launched the funding opportunity announcement for the third cohort of its regional biomedical proof-of-concept and accelerator program, the Research Evaluation and Commercialization Hubs. On Dec.

The Department of Energy’s Office of Science recently announced new requirements for all research proposal applications. Applicants must submit a plan for Promoting Inclusive and Equitable Research — or PIER Plan — with their research proposal during the solicitation process. The PIER Plans will be required beginning in FY 2023 and will require investigators to describe strategies to promote diversity, equity, inclusion, and accessibility in all research projects.

The Convergence Accelerator, a program developed by the National Science Foundation (NSF) to invest in research towards developing high-impact solutions for societal issues, requests topic ideas for the 2023 cohort in a Dear Colleague Letter Request for Information (DCL/RFI). This program follows a three-tiered process, including topic ideation and convergence research phases one and two.

New fiscal year (FY) 2021 Higher Education Research & Development (HERD) survey data released by the National Science Foundation (NSF) reveals a $3.4 billion (4%) increase in research and development (R&D) spending by institutions of higher education ($86.5 to $89.9 billion), driven almost entirely by a decades high federal government R&D funding increase of $3 billion.

Recent findings from a study titled The Death of Downtown? Pandemic Recovery Trajectories across 62 North American Cities, conducted by a group of six researchers at the University of California’s Berkeley campus's Institute of Governmental Studies found that U.S.

A recent announcement from the White House Office of Science and Technology Policy (OSTP) included major updates requiring open access to federally funded research. The new guidance will require federal agencies to ensure that all taxpayer-funded research is immediately available to the public, disallowing the previous optional 12-month embargos.

In a move designed to strengthen southwest Pennsylvania’s role in life sciences research, the University of Pittsburgh and Richard King Mellon Foundation last month announced a $100 million gift to help fund a bioresearch and development facility.

Congress passed the bipartisan infrastructure framework, formally, the Infrastructure and Investment Jobs Act, and President Joe Biden is expected to sign it the week of Nov. 15. While small as a percentage of the trillion-dollar total, there are a number of proposed items that can support regional innovation economies, with broadband being the highest funded.

As U.S. research institutions face funding uncertainty, countries and universities worldwide are launching initiatives to lure away our scientific talent:

How one applies and has their proposal reviewed to gain a small share of the world's largest funding source for life science research is changing. The following highlights modifications affecting grant applications submitted to the National Institutes of Health for due dates on or after January 25, 2025, as posted on their Implementation of New Initiatives and Policies page.

As the federal R&D budget has grown, peer review committee compositions changed, and federal research awards have grown in size, the threshold to obtain the designation as a Carnegie R1 university of $50 million in total research spending to earn the designation was met by 42 additional universities for the first time, bringing the total to 187 nationwide.

In a recent State of the Science address, National Academy of Sciences President Marcia McNutt called attention to what she sees as an alarming trend: the federal contribution to basic research is stagnating while industry funding is rising. The federal share of U.S. spending on basic research, she said, was down from about 60% in 2011 to 40% in 2021.